 OCALA, Fla., Dec. 06, 2021 GLOBE NEWSWIRE -- AIM ImmunoTech Inc. NYSE American: AIM today announced that Thomas Equels, Chief Executive Officer of AIM, will be participating in two upcoming investor conferences. 